Transplantation Medicine

Stem Cell Therapy Technology Offers Promise In Cancer Treatment

Published in Blood Weekly, November 1st, 2001

Aastrom Biosciences' SC-I Bone Marrow Cell Therapy may offer thousands of cancer patients undergoing stem cell transplants an effective and less invasive approach to obtain the therapeutic amounts of stem cells needed to promote blood cell recovery.

A new clinical study demonstrated the emerging therapeutic value of the SC-I product for bone marrow stem cells which were expanded outside the body for the restoration of normal blood and immune system function in cancer patients. The multi-center study, conducted at Hackensack University Medical Center (HUMC), Loyola University Medical Center and the Southwest Texas Cancer Institute, included 31 adult subjects with...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2001-11-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry